Presymptomatic genetic testing for neurodegenerative diseases can help patients make effective treatment decisions, but the medical profession needs to ensure that the increasing use of the tests is done responsibly.
The Do Not Resuscitate policy in many hospitals brings about ethical questions regarding hospital policy towards terminally ill patients and end-of-life care.
Two physicians argue that disaster preparedness for bioterrorist attacks diverts health care resources from other critical medical and public health needs.
A centralized registry to provide information to consumers regarding the effectiveness of clinical trials is needed to help patients make informed decisions about treatment.